Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

Mohammad Abumayyaleh,Katharina Koepsel,Julia W. Erath,Thomas Kuntz,Norbert Klein,Boldizsar Kovacs,Firat Duru,Ardan M. Saguner,Christian Blockhaus,Dong‐In Shin,Fabienne Kreimer,Michael Gotzmann,Hendrik Lapp,Thomas Beiert,Assem Aweimer,Andreas Mügge,Christel Weiß,Ibrahim El‐Battrawy,Ibrahim Akin
DOI: https://doi.org/10.1002/ehf2.15141
2024-11-01
ESC Heart Failure
Abstract:Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an 'obesity paradox' has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored. Methods In a multicentre international registry, we retrospectively collected data from a consecutive series of 1003 patients. These patients were divided into three body mass index (BMI) groups: 30 kg/m2 (n = 272), with BMI > 30 kg/m2 defined as the reference category. Demographics, indications, adherence, WCD shocks, arrhythmic events, rehospitalization due to cardiovascular causes, and mortality were analysed. Results At 3 month follow‐up, patients with a BMI > 30 showed the greatest improvement in left ventricular ejection fraction (LVEF) at 51.4%, significantly higher than the 41.4% in those with a BMI 30 group (36.8%) compared with others, although not significantly. Rehospitalization due to cardiovascular causes was significantly lower in the BMI > 30 group (55.4%) compared with the BMI 25–30 group (70.9%; P = 0.048), but similar to the BMI 30 group (5.9%) compared with the BMI
cardiac & cardiovascular systems
What problem does this paper attempt to address?